Researcher Yamasaki from DMPK BU to Present a Poster at the 16th Annual Conference on Biomolecular Screenology

2025.11.18

Researcher Yamasaki from the DMPK Business Unit, will deliver a poster presentation at the 16th Annual Conference of Conference on Biomolecular Screenology, to be held in Funabori, Tokyo in Japan.
If you plan to attend the conference, we encourage you to join the session and hear the presentation.

Conference Name:the 16th Annual Conference of Conference on Biomolecular Screenology

Date & Time: November 28, 13:20-13:50 (JST)

Location: Tower Hall Funabori, Tokyo Edogawa, Japan

Title: Improving the efficiency of HT-ADMET assays by development of the assay request system

Poster number: B13

Presentation Summary
High-throughput ADMET (HT-ADMET) screening must be performed with a wide variety of compounds, in large quantities, with short turnaround times, and at low cost to achieve rapid compound selection during the lead compound creation and optimization phase in early drug discovery research.
We developed CARS (Compound & Assay Request System) to address this need. This poster introduces CARS’s features and presents our efforts and achievements in streamlining each step of HT-ADMET screening – request approval, compound supply, assay execution, measurement, data analysis, reporting.

Axcelead DDP’s Soulution
Our HT-ADMET service is utilized by many clients. This allows us to conduct regular testing even for assays where individual companies lack sufficient compound numbers for consistent testing. Regular testing enables us to identify and resolve challenges in each assay, continuously refining the testing system to be more user-friendly for clients in terms of test quality, cost, and turnaround time. We also develop customized testing systems to address specific challenges faced by individual companies. When considering HT-ADMET screening, please do not hesitate to consult with us.